Viral Hepatitis

You have full text access to this OnlineOpen article

Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B†

  1. Fiona Fernandes1,
  2. Daniel S. Poole1,
  3. Spencer Hoover1,
  4. Rannveig Middleton1,
  5. Adin-Cristian Andrei2,
  6. Justin Gerstner1,
  7. Rob Striker1,‡,*

Article first published online: 28 JUN 2007

DOI: 10.1002/hep.21809

Issue

Hepatology

Hepatology

Volume 46, Issue 4, pages 1026–1033, October 2007

Additional Information

How to Cite

Fernandes, F., Poole, D. S., Hoover, S., Middleton, R., Andrei, A.-C., Gerstner, J. and Striker, R. (2007), Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B. Hepatology, 46: 1026–1033. doi: 10.1002/hep.21809

Author Information

  1. 1

    Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI

  2. 2

    Department of Biostatistics & Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, WI

  1. ‡

    fax: 608-262-8418

*University of Wisconsin, 1300 University Avenue, MSC, Madison, WI 53706

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 25 SEP 2007
  2. Article first published online: 28 JUN 2007
  3. Manuscript Accepted: 7 MAY 2007
  4. Manuscript Received: 24 MAR 2007

Funded by

  • UW School of Medicine and Public Health from “The Wisconsin Partnership Fund for a Healthy Future”. Grant Number: K08AI055750-03
  • National Institutes of Health (NIH)
  • American Cancer Society Research Scholar Grant. Grant Number: 07-077-01

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (604K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Francesco Azzaroli, Laura Turco, Andrea Lisotti, Paolo Cecinato, Claudio Calvanese, Federica Buonfiglioli, Monica Cevenini, Marco Montagnani, Giuseppe Mazzella, Alisporivir for the treatment of chronic HCV, Future Virology, 2012, 7, 1, 9

    CrossRef

  2. 2
    Robert Flisiak, Jerzy Jaroszewicz, Iwona Flisiak, Tadeusz Łapiński, Update on alisporivir in treatment of viral hepatitis C, Expert Opinion on Investigational Drugs, 2012, 21, 3, 375

    CrossRef

  3. 3
    Qiuwei Pan, Hugo W. Tilanus, Herold J. Metselaar, Harry L. A. Janssen, Luc J. W. van der Laan, Virus–drug interactions—molecular insight into immunosuppression and HCV, Nature Reviews Gastroenterology & Hepatology, 2012,

    CrossRef

  4. 4
    Priscilla L Yang, Min Gao, Kai Lin, Qingsong Liu, Valerie A Villareal, Anti-HCV drugs in the pipeline, Current Opinion in Virology, 2011, 1, 6, 607

    CrossRef

  5. 5
    Philippe A. Gallay, Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agents, Immunologic Research, 2011, 52, 3, 200

    CrossRef

  6. 6
    B. E. Pickett, R. Striker, E. J. Lefkowitz, Evidence for separation of HCV subtype 1a into two distinct clades, Journal of Viral Hepatitis, 2011, 18, 9
    Direct Link:
  7. 7
    David L. Wyles, The Potential for Combination Treatment Using STAT-C Drugs, Current Hepatitis Reports, 2011, 8, S1, 27

    CrossRef

  8. 8
    Min Gao, Richard E. Nettles, Makonen Belema, Lawrence B. Snyder, Van N. Nguyen, Robert A. Fridell, Michael H. Serrano-Wu, David R. Langley, Jin-Hua Sun, Donald R. O’Boyle II, Julie A. Lemm, Chunfu Wang, Jay O. Knipe, Caly Chien, Richard J. Colonno, Dennis M. Grasela, Nicholas A. Meanwell, Lawrence G. Hamann, Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect, Nature, 2010, 465, 7294, 96

    CrossRef

  9. 9
    U. Chatterji, M. D. Bobardt, P. Lim, P. A. Gallay, Cyclophilin A-independent recruitment of NS5A and NS5B into hepatitis C virus replication complexes, Journal of General Virology, 2010, 91, 5, 1189

    CrossRef

  10. 10
    Kai Lin, Development of novel antiviral therapies for hepatitis C virus, Virologica Sinica, 2010, 25, 4, 246

    CrossRef

  11. 11
    Udayan Chatterji, Precious Lim, Michael D. Bobardt, Stefan Wieland, Daniel G. Cordek, Gregoire Vuagniaux, Francis Chisari, Craig E. Cameron, Paul Targett-Adams, Tanya Parkinson, Philippe A. Gallay, HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A–cyclophilin A interaction to cyclophilin inhibitors, Journal of Hepatology, 2010, 53, 1, 50

    CrossRef

  12. 12
    L. Alex Gaither, Jason Borawski, Leah J. Anderson, Kara A. Balabanis, Piroska Devay, Gerard Joberty, Christina Rau, Markus Schirle, Tewis Bouwmeester, Craig Mickanin, ShanChuan Zhao, Chad Vickers, Lac Lee, Gejing Deng, Jeremy Baryza, Roger A. Fujimoto, Kai Lin, Teresa Compton, Brigitte Wiedmann, Multiple cyclophilins involved in different cellular pathways mediate HCV replication, Virology, 2010, 397, 1, 43

    CrossRef

  13. 13
    Tarun K. Narang, Will Ahrens, Mark W. Russo, Post–liver transplant cholestatic hepatitis C: A systematic review of clinical and pathological findings and application of consensus criteria, Liver Transplantation, 2010, 16, 11
    Direct Link:
  14. 14
    Helen Waller, Udayan Chatterji, Philippe Gallay, Tanya Parkinson, Paul Targett-Adams, The use of AlphaLISA technology to detect interaction between hepatitis C virus-encoded NS5A and cyclophilin A, Journal of Virological Methods, 2010, 165, 2, 202

    CrossRef

  15. 15
    Julie A. Heck, Xiao Meng, David N. Frick, Cyclophilin B stimulates RNA synthesis by the HCV RNA dependent RNA polymerase, Biochemical Pharmacology, 2009, 77, 7, 1173

    CrossRef

  16. 16
    Philippe A. Gallay, Cyclophilin Inhibitors, Clinics in Liver Disease, 2009, 13, 3, 403

    CrossRef

  17. 17
    Sandra Ciesek, Eike Steinmann, Heiner Wedemeyer, Michael P. Manns, Johann Neyts, Norbert Tautz, Vanesa Madan, Ralf Bartenschlager, Thomas von Hahn, Thomas Pietschmann, Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A, Hepatology, 2009, 50, 5
    Direct Link:
  18. 18
    Ken-ichi Abe, Masanori Ikeda, Yasuo Ariumi, Hiromichi Dansako, Takaji Wakita, Nobuyuki Kato, HCV genotype 1b chimeric replicon with NS5B of JFH-1 exhibited resistance to cyclosporine A, Archives of Virology, 2009, 154, 10, 1671

    CrossRef

  19. You have free access to this content19
    Kaku Goto, Koichi Watashi, Daisuke Inoue, Makoto Hijikata, Kunitada Shimotohno, Identification of cellular and viral factors related to anti-hepatitis C virus activity of cyclophilin inhibitor, Cancer Science, 2009, 100, 10
    Direct Link:
  20. 20
    Zhe Liu, John M. Robida, Sreedhar Chinnaswamy, Guanghui Yi, Jason M. Robotham, Heather B. Nelson, Andre Irsigler, C. Cheng Kao, Hengli Tang, Mutations in the hepatitis C virus polymerase that increase RNA binding can confer resistance to cyclosporine A, Hepatology, 2009, 50, 1
    Direct Link:
  21. 21
    Nicholas A. Meanwell, John F. Kadow, Paul M. Scola, Annual Reports in Medicinal Chemistry Volume 44, 2009,

    CrossRef

  22. 22
    T. Reiberger, S. Rasoul-Rockenschaub, A. Rieger, P. Ferenci, A. Gangl, M. Peck-Radosavljevic, Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection, European Journal of Clinical Investigation, 2008, 38, 6
    Direct Link:
  23. 23
    Leonardo L. Schiavon, Roberto J. Carvalho-Filho, Janaína L. Narciso-Schiavon, Denize V. Barbosa, Valéria P. Lanzoni, Maria Lucia G. Ferraz, Antonio Eduardo B. Silva, Impact of cyclosporine-based immunosuppressive therapy on liver histology of hepatitis C virus–infected renal transplant patients, Hepatology, 2008, 48, 1
    Direct Link:
  24. 24
    Daniel S Pratt, Liver disorders, Current Opinion in Gastroenterology, 2008, 24, 3, 265

    CrossRef

  25. 25
    Adnan Said, Michael R Lucey, Liver transplantation: an update 2008, Current Opinion in Gastroenterology, 2008, 24, 3, 339

    CrossRef

  26. 26
    Kai Lin, Discovery of Cyclophilin Inhibitor NIM811 as a Novel Therapeutic Agent for HCV,
    Direct Link:
View Full Article (HTML) Get PDF (604K)